Among 41 consecutive primary pT2-4 urothelial bladder carcinomas from which 1–15 (average 6.4) whole sections were analyzed, MTAP was homogeneously deficient in 34.1%, heterogeneously deficient in 4.9% and homogeneously retained in 61.0%. This evidence concerns the gene MTAP and bladder transitional cell carcinoma.